Chemomab Therapeutics Ltd.
CMMB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534248
In the last 90 days, Chemomab Therapeutics Ltd. insiders filed 0 open-market purchases and 1 sale; 13 institutions reported holding it in 13F filings for Q2 2026, worth $615.3K in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Chemomab Therapeutics Ltd. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 15 | 14 | −1 |
| Shares | 3.24M | 3.29M | +46.5K (+1.4%) |
| Value | $35.9M | $22.7M | −$13.2M (−36.8%) |
New holders (2)
Institutions that held Chemomab Therapeutics Ltd. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 22,441 | $155.0K | 0.02% |
| Gsa Capital Partners LLP | 11,277 | $78.0K | 0.01% |
Sold out (3)
Institutions that held Chemomab Therapeutics Ltd. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Spire Wealth Management | 500 | $6.00K |
| Tower Research Capital LLC (TRC) | 49 | $1.00K |
| Ironwood Financial, llc | 7 | $0 |